Risk factor
Very high price volatility
Profitability factor
Greatly overvalued vs peers
About
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a...
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITDA,
Target Price
The average target price of INSP is 86 and suggests 40% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
Buy
Sell